Articles tagged with Cancer Cells
Researchers propose natural adaptive therapies to keep cancer in check by mimicking the immune system's approach. These therapies aim to stabilize tumor size and slow resistance evolution.
Researchers at IRB Barcelona and Vrije Universiteit Brussel have identified camelid nanobodies effective against EGF, a growth factor dysregulated in cancer cells. These nanobodies could provide a potential treatment for patients developing resistance to existing EGFR inhibitors.
Researchers at Penn discovered a new, rare mechanism that allows leukemia cells to relapse after CAR T cell therapy by masking the target protein CD19. This finding emphasizes the need for precise manufacturing processes to ensure the effectiveness of this treatment.
A new study suggests that organs affected by autoimmune disease can actively fight back by exhausting immune cells that cause damage. The research found that these cells exhibit characteristics similar to those used by cancer cells to evade the immune system.
Subtle changes in protein regulation can cause severe face and brain developmental abnormalities, highlighting the importance of striking a healthy balance between too little and too much cell death. The study suggests that excessive or inadequate cell death during embryonic development can lead to devastating birth defects or cancer.
Researchers found that for 85% of genes, noise magnitude is higher in the last step compared to the first. This discovery challenges the long-held assumption of a streamlined process and may impact disease treatment strategies.
Researchers developed a new cell culture platform to observe cancer cells' never-before-seen behaviors, revealing the mechanisms behind pancreatic cancer's clinical properties. The study shows that cancer cells can self-organize into micro-tumors and evade the immune system by releasing chemical markers on their surfaces.
Salk researchers discover that manipulating nuclear pores can increase their numbers in healthy cells, mimicking those found in cancer cells. This breakthrough could lead to a new way to fight cancer by targeting nuclear pores.
Researchers at UC San Diego School of Medicine discovered that ubiquitination influences GPCR function and promotes inflammation. Existing cancer drugs targeting enzymes involved in ubiquitination may be repurposed to treat vascular inflammation.
Researchers at the University of Oregon have created a new class of fluorescent dyes, called nanohoops, that can be used to track multiple biological activities in live cells. These circular structures emit colors based on their size and can be guided to specific sites within cells.
Researchers found that increased antioxidant enzyme expression and decreased NADPH-oxidase activity hinder treatment efficiency. This study reveals a redox-dependent mechanism of drug resistance development in ovarian cancer cells.
A study led by the University of Exeter Medical School found that disrupting genes and pathways regulating splicing factors can reverse signs of aging in cells. Disrupting ERK and AKT pathways reduced senescent cells, increasing splicing factors and leading to cellular rejuvenation.
Researchers developed a new framework combining three methods to find large DNA mutations in cancer cells. The approach reveals how these mutations contribute to cancer development and can help predict effective treatment plans.
Researchers developed a DNA-based test to predict which patients with acute myeloid leukemia (AML) are at risk of relapse. The test can identify treatment-resistant cancer cells three weeks after transplantation, allowing for earlier therapeutic intervention.
Researchers at NUST MISIS and University of Calgary create method to monitor virus spread and immune system response in real-time using intravital microscopy. This breakthrough enables visualization of virus behavior in tissues and organs of living animals.
A $2 million phase 2 grant will be used to further develop a compound that has shown efficacy in preclinical studies against treatment-resistant multiple myeloma. The goal is to create a one-two punch when administered with proteasome inhibitors, making it an effective treatment option for patients.
Researchers found liver cells do not need ORC1 to replicate DNA, a key component of cell division. This process, called an endocycle, allows cells to copy their DNA multiple times without dividing, resulting in larger cells with more DNA. Understanding this mechanism could help explain how cancer arises and how it spreads.
Researchers at UT Austin have developed a new approach to treating cancer using enzyme therapy, which boosts the immune system by degrading kynurenine, a metabolite that suppresses the immune system. The treatment could prove effective in treating various types of cancers and is expected to initiate clinical trials soon.
Scientists develop FliptR, a fluorescent molecule that measures cell membrane tension, revealing how cells adapt their surface to volume changes. The discovery paves the way for applications in cancer cell detection and membrane tension regulation.
Researchers developed an immunotherapy that induces antitumor immunity by provoking necroptosis in cancer cells, destroying tumors while protecting against secondary tumor formation. The treatment provides protection against disseminated tumors and stimulates the immune system to attack persistent surviving cancer cells.
Researchers at NUST MISIS have developed a system that improves cancer diagnosis accuracy and provides opportunities for targeted therapy. The magnetoferritin compound, introduced into the body before diagnosis, enhances contrast signals in imaging and targets tumor cells for destruction.
Researchers at Hebrew University of Jerusalem have developed a new biological drug that has shown a 50% cure rate in lab mice with acute leukemia. The single-molecule drug targets multiple leukemic proteins, making it difficult for cancer cells to evade therapy and reducing the need for multiple treatments.
University of Bristol researchers have discovered a way to exploit hypoxia to kill cancer cells without harming healthy tissue. The study found that a specific receptor, GPRC5A, can be targeted using genetic techniques to trigger cancer cell death.
Researchers found that nanoparticles and contaminants can be deadly to human cells, especially when combined. Exposure to silver nanoparticles alone was less toxic, but combining them with cadmium ions increased cell death by 60%. The study highlights the need for regulations on nanoparticle releases into the environment.
Scientists have introduced a microfluidic chip for manipulation and nucleic-acid analysis of individual cells. The technique uses dielectrophoresis to trap and analyze cells efficiently, overcoming conventional methods' limitations. This innovation paves the way for personalized medicine and improved diagnostics.
Research suggests an inverse relationship between fever and cancer incidence, potentially linked to enhanced gamma/delta T cell activity. This mechanistic hypothesis proposes that repeated exposure to fever boosts the ability of these T cells to detect cellular abnormalities and destroy malignant cells.
A study by researchers at the Instituto Gulbenkian de Ciencia found that the Spindle Assembly Checkpoint, a mechanism that regulates cell division, can sometimes be counterproductive. This checkpoint can increase genetic errors when cells have irreparable problems with chromosome cohesion.
Researchers at H. Lee Moffitt Cancer Center suggest that lowering pH inside cancer cells can slow down the growth and spread of the disease. By analyzing how variations in pH affect metabolic enzymes, they identified potential therapeutic targets for breast cancer treatment.
A new chemical compound has been developed and tested by scientists at the University of Huddersfield, which attracts vulnerable cancer cells while leaving healthy cells untouched. The compound contains ruthenium and is showing promising results in laboratory tests.
Researchers at Utah State University have developed a new flavonoid molecule that can release carbon monoxide in a controlled manner, triggering cancer cell death and reducing inflammation. The unique molecules are trackable, targetable, and triggerable using visible light.
Researchers have gained new understanding of how autophagosomes seal off waste material, with a key role identified for ESCRT complexes. This breakthrough could lead to new cancer treatments by inhibiting autophagy closure.
Researchers discovered an anti-cancer gene called LIF6 in elephants that helps destroy cells with damaged DNA, potentially preventing cancer. This gene emerged around 25-30 million years ago and may have played a key role in enabling the growth of modern elephants.
Scientists have created specialized delivery methods using nucleic acid-based nanostructures to target cancer cells while leaving normal cells intact. The new approach utilizes aptamers to bind to specific receptors on cancer cells, allowing for the targeted delivery of chemotherapeutic drugs.
Researchers at University of Illinois Chicago discovered that a mutation in the NPM1 gene helps improve sensitivity to chemotherapy in patients. The study found that patients with this mutation tend to respond better to chemotherapy and have higher rates of remission.
Researchers identified specific gene activity in each cell, revealing that Wilms' tumour cells have the same characteristics as normal developing kidney cells. Adult renal carcinoma cells were found to be a version of rare healthy adult kidney cells called PT1.
Researchers identify MUC5AC gene as a key player in KRAS-mutant non-small cell lung cancers, which are resistant to current treatments. Inhibiting this gene may lead to new therapeutic strategies against KRAS-driven lung cancer.
Researchers developed a new sensor that detects hydrogen peroxide levels in human cells to identify effective chemotherapy drugs. The sensor can be used to screen existing drugs and predict success in individual patients' tumors. This breakthrough could lead to more targeted and effective cancer treatments.
Researchers identify a new mechanism used by Henipaviruses to hijack the DNA-damage response machinery, allowing them to prosper in cells. This discovery may lead to the development of new anti-viral therapies.
Researchers investigate how a group of cells breaks off from a colony, leading to large-scale metastasis. Mechanical engineer Amit Pathak aims to understand the mechanisms behind disease pathways and fundamental cell behavior.
Rice University's Luay Nakhleh has received $1.5 million in grants from the NSF to develop algorithms that can infer evolutionary histories of tumor cells, helping researchers understand why some cancer cells spread and mutate differently.
A computational study has shown that cancer cells proliferate less and are more vulnerable to acidic conditions than initially thought. The researchers have identified potential therapeutic targets by analyzing how variations in pH affect metabolic enzyme activity, providing opportunities for new treatments.
Senescent cells, also known as 'zombie cells,' interfere with tissue function and contribute to aging diseases. Researchers have designed a nano-carrier that selectively targets these cells, releasing drugs to kill them and improving therapeutic outcomes in pulmonary fibrosis and cancer models.
Researchers used proteomics to study the basic biology of Alzheimer's disease, cancer, and listeriosis. They found that BACE1 inhibition increases amyloid precursor protein and other substrates in Alzheimer's, while butyrate activates mitochondrial oxidation and suppresses tumor growth in colorectal cancer cells.
Leukemia cells infiltrate the central nervous system by grabbing onto laminin proteins and zipping down into the meninges region where cerebral spinal fluid circulates. This discovery arms researchers with new ways to target this pathway and potentially shut it down.
Researchers at the University of Adelaide have designed a new molecule that successfully targets PCNA, a protein essential for DNA replication in rapidly dividing cancer cells. The molecule shows increased potency over existing PCNA inhibitors and is likely to cause fewer side effects.
A team of international researchers has mapped the family trees of cancer cells in AML to understand its response to enasidenib and how it can be combined with other anti-cancer drugs. The study provides clues about how AML cells become resistant to therapy and may help design future therapy trials.
Scientists have identified a protein called SIRT7 that protects cells against senescence by keeping certain genes turned off. This function is crucial for preventing age-related deterioration and could lead to therapies targeting cellular senescence.
Researchers at Cincinnati Children's Hospital Medical Center have found a potential therapeutic target for acute myeloid leukemia (AML), a deadly blood cancer with a dismal survival rate. By targeting the F-box protein Skp2, they were able to kill AML cells and induce healthy white blood cell regeneration in preclinical tests.
Researchers at Kumamoto University identified optimal PEF conditions for increasing cell membrane permeability to calcium. The study found that larger electric fields produced high calcium intake rates, while smaller fields showed undetectable intake rates initially followed by increased rates.
Carbon nanotubes enable the creation of 'smart' materials for powering electronics, with potential applications in military technology and medical research. The unique properties of carbon nanotubes make them suitable for replacing traditional materials such as copper wire and polyester fibers.
Researchers discovered that pancreatic cancer cells' ability to alter their characteristics and shape affects where metastases form. The presence of E-cadherin protein controls this process, with its absence leading to lung metastases but not liver metastases.
Researchers at Mayo Clinic have discovered how the DNA repair protein 53BP1 relocates to chromosomes to fix damage, using RNA molecules as an off/on switch. This finding could lead to new therapies for ovarian cancer by targeting a specific protein called TIRR.
Researchers at Karolinska Institutet discovered a built-in molecular brake on human cell division that ensures two complete copies of DNA before cell division, preventing DNA damage and cancer. This process restricts growth to prevent lethal diseases like cancer.
Researchers at UCLA have developed synthetic T cells with near-perfect facsimiles of human T cells, which could lead to more effective treatments for cancer and autoimmune diseases. The artificial cells can boost the immune system and interact with immune cells, making them a promising tool in the fight against infections.
Hollings Cancer Center researchers discovered that cancer cells protect their telomeres from damage to prevent cell death, contributing to their long lifespan. By inhibiting this mechanism, the researchers hope to develop a new treatment for cancer and potentially delay aging.
Researchers have developed a new method to diagnose oral squamous cell carcinomas (OSCCs) earlier, using the mechanical properties of cancer cells. By testing the relaxation behavior after stress release, they found that OSCC cells are 'softer' and exhibit faster contraction than benign cells.
Researchers found that cancer cells produce excessive BCL-2 protein due to a ribosome defect, helping them survive chemotherapy. A drug suppressing this protein has shown promise in treating T-cell leukaemia with similar defects.
Researchers at NYU School of Medicine discovered that mTORC1 regulates cell crowding, which can cause proteins to solidify and interfere with cellular functions. The study suggests that malfunctioning mTORC1 may contribute to the development of aging diseases.
Scientists have discovered a new gene expression mechanism involving the Spt6 protein, which helps regulate messenger RNA levels in cells. The discovery suggests a potential target for treating cancers and other diseases, as abnormal RNA levels can lead to diseases such as cancer.
A new vehicle peptide has been identified for delivering therapeutically effective peptides to cancer cells. The peptide, termed peptide 1, mimics the dimerization arm of the EGF receptor, which is involved in cellular signal transductions and cancer progression.